SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated
IMMU 41.32-2.3%Jul 10 4:00 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
Recommended by:
bobbseytwins2001
captcobra1
corndog
drtom1234
EMU2
erippetoe
idahoranch1
patlawche11
rodneyh07
vt413
To: czboy who wrote (49675)1/23/2019 3:02:59 PM
From: li351110 Recommendations   of 57180
 
> The CRL is a total rejection of their manufacturing scheme: "chemistry " , "data integrity " could be very serious .

Complete nonsense. The manufacturing scheme for monoclonal antibodies is pretty much cookbook these days.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext